Abstract

No AccessJournal of UrologyTranslational Research Article26 May 2023Editorial CommentThis article comments on the following:Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance Udit Singhal and Simpa S. Salami Udit SinghalUdit Singhal Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan Department of Urology, Mayo Clinic, Rochester, Minnesota More articles by this author and Simpa S. SalamiSimpa S. Salami Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000003507.01AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareFacebookLinked InTwitterEmail "Editorial Comment." The Journal of Urology, Publish Ahead of Print, pp. REFERENCES 1. Molecular biomarkers in localized prostate cancer: ASCO guideline. J Clin Oncol. 2020; 38:1474-1494. Crossref, Medline, Google Scholar 2. Transcriptomic heterogeneity in multifocal prostate cancer. JCI Insight. 2018; 3(21):e123468. Crossref, Medline, Google Scholar 3. Multimodal biomarkers that predict the presence of Gleason pattern 4: potential impact for active surveillance. J Urol. 2023; 210(2):000. Google Scholar 4. . EDRN Prostate MRI Biomarker Study (P-MRI); 2023. https://ClinicalTrials.gov/show/NCT03784924. Google Scholar Submitted April 19, 2022; accepted April 20, 2023; published 000. © 2023 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of Urology1 May 2023Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance Advertisement Copyright & Permissions© 2023 by American Urological Association Education and Research, Inc.MetricsAuthor Information Udit Singhal Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan Department of Urology, Mayo Clinic, Rochester, Minnesota More articles by this author Simpa S. Salami Department of Urology, Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan More articles by this author Expand All Submitted April 19, 2022; accepted April 20, 2023; published 000. Advertisement PDF downloadLoading ...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call